Trade

with

Auxilium Pharmaceuticals Inc
(NASDAQ: AUXL)
AdChoices
30.75
-0.37
-1.19%
After Hours :
30.75
0.00
0.00%

Open

31.08

Previous Close

31.12

Volume (Avg)

3.17M (2.06M)

Day's Range

30.72-31.54

52Wk Range

16.51-33.00

Market Cap.

1.57B

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

50.35M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 400.72M

    • Net Income

    • -18.07M

    • Market Cap.

    • 1.57B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -35.76

    • PEG (Price/Earnings Growth) Ratio

    • 0.66

    • Beta

    • 0.69

    • Forward P/E

    • 19.69

    • Price/Sales

    • 3.82

    • Price/Book Value

    • 8.73

    • Price/Cash flow

    • -69.44

      • EBITDA

      • -11.85M

      • Return on Capital %

      • -13.18

      • Return on Equity %

      • -59.66

      • Return on Assets %

      • -13.18

      • Book Value/Share

      • 3.56

      • Shares Outstanding

      • 50.35M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 32.33

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 4.22

        • Cashflow Estimate

        • 4.42

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -17.40

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 26.16

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 70.93

            • 64.72

            • Pre-Tax Margin

            • -35.80

            • 13.77

            • Net Profit Margin

            • -35.76

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 77.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -10.40

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.99

              • 0.33

              • Current Ratio

              • 0.99

              • 1.52

              • Quick Ratio

              • 0.60

              • 0.87

              • Interest Coverage

              • -2.87

              • 6.77

              • Leverage Ratio

              • 6.22

              • 1.91

              • Book Value/Share

              • 3.56

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -10.67

                • 63.69

                • P/E Ratio 5-Year High

                • -13.20

                • 237.47

                • P/E Ratio 5-Year Low

                • -4.66

                • 19.71

                • Price/Sales Ratio

                • 3.82

                • 3.64

                • Price/Book Value

                • 8.73

                • 3.39

                • Price/Cash Flow Ratio

                • -69.44

                • 21.79

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -59.66

                        (-20.10)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • -13.18

                        (-6.40)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • -17.23

                        (-18.30)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • -

                      • 27.79k

                      • Inventory Turnover

                      • 2.49

                      • 1.80

                      • Asset Turnover

                      • 0.37

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -68.08M
                      Operating Margin
                      -16.99
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -69.44
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      68.78%

                      Mutual Fund Ownership

                      51.72%

                      Float

                      99.46%

                      5% / Insider Ownership

                      2.42%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • PowerShares Dynamic Pharmaceuticals Port

                      •  

                        2,177,507

                      • 0.00

                      • 4.51

                      • Fidelity® Growth Company Fund

                      •  

                        1,651,300

                      • 0.00

                      • 3.28

                      • SPDR® S&P Pharmaceuticals ETF

                      •  

                        1,423,377

                      • 0.00

                      • 2.90

                      • ClearBridge Small Cap Growth Fund

                      •  

                        1,391,855

                      • -1.05

                      • 2.76

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        1,004,721

                      • 0.00

                      • 2.00

                      • Fidelity® Select Health Care Portfolio

                      •  

                        1,000,000

                      • 0.00

                      • 1.99

                      • Vanguard Small Cap Index

                      •  

                        874,642

                      • -0.16

                      • 1.74

                      • Vanguard Total Stock Mkt Idx

                      •  

                        810,807

                      • 0.43

                      • 1.61

                      • iShares Russell 2000 (AU)

                      •  

                        781,072

                      • -1.02

                      • 1.59

                      • Invesco Global Health Care Fd

                      •  

                        759,948

                      • 0.00

                      • 1.60

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Deerfield Management Co

                      •  

                        6,267,382

                      • +144.18%

                      • 12.47

                      • Fidelity Management and Research Company

                      •  

                        5,987,695

                      • +0.01%

                      • 11.91

                      • Palo Alto Investors, LLC

                      •  

                        4,854,631

                      • -49.87%

                      • 9.66

                      • Paulson & Company Inc

                      •  

                        4,000,000

                      • 0.00%

                      • 7.96

                      • Vanguard Group, Inc.

                      •  

                        3,022,301

                      • +0.16%

                      • 6.01

                      • State Street Corp

                      •  

                        2,284,242

                      • +20.73%

                      • 4.54

                      • Wellington Management Company, LLP

                      •  

                        2,190,023

                      • +33.80%

                      • 4.36

                      • BlackRock Fund Advisors

                      •  

                        2,060,593

                      • -3.56%

                      • 4.10

                      • Artal Group S A

                      •  

                        2,015,000

                      • +46.55%

                      • 4.01

                      • TAMRO Capital Partners LLC

                      •  

                        1,889,738

                      • -4.73%

                      • 3.76

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Distressed

                      Style

                      Small Growth

                      Auxilium Pharmaceuticals, Inc., incorporated in the state of Delaware in July 1999. The Company is a specialty biopharmaceutical company which develops and markets products for specialist audiences. The Company now have a portfolio o...moref 12 approved products, including one product with two indications. Among other products in the U.S., Auxilium markets Testim (testosterone gel) for the topical treatment of hypogonadism, TESTOPEL (testosterone pellets) a long-acting implantable testosterone replacement therapy ("TRT") product, STENDRA (avanafil), an oral erectile dysfunction ("ED") therapy, Edex (alprostadil for injection), an injectable treatment for ED, Osbon ErecAid, the leading vacuum device for aiding ED, XIAFLEX (collagenase clostridium histolyticum or "CCH") for the treatment of Peyronie's diseas...moree ("PD" or "Peyronie's") and XIAFLEX for the treatment of Dupuytren's contracture ("DC" or "Dupuytren's"). We also have programs in Phase 2 clinical development for the treatment of Frozen Shoulder syndrome and cellulite, Striant, a buccal TRT, XIAFLEX for the treatment of PD in men with a palpable plaque and a curvature deformity of thirty degrees or greater at the start of therapy which was launched in the U.S. in January 2014 and is the first and only FDA-approved non-surgical treatment for PD. Approximately 75% of the Company’s product shipments are to only three wholesalers: Cardinal Health, Inc., McKesson Corporation and AmerisourceBergen Corporation. The Company faces competition from competitors in North America, Europe and elsewhere from pharmaceutical companies, specialty pharmaceutical companies and biotechnology firms, universities and other research institutions and government agencies that are developing and commercializing pharmaceutical products.lessless

                      Key People

                      Mr. Adrian Adams

                      CEO/Director/President

                      Mr. Rolf A. Classon

                      Chairman of the Board/Director

                      Mr. Andrew Saik

                      Director/CFO

                      Mr. Mark A. Glickman

                      Executive VP, Divisional

                      Benjamin J Del Tito,Jr

                      Executive VP, Divisional

                      • Auxilium Pharmaceuticals Inc

                      • 640 Lee Road

                      • Chesterbrook, PA 19087

                      • USA.Map

                      • Phone: +1 484 321-5900

                      • Fax: +1 484 321-5999

                      • auxilium.com

                      Incorporated

                      1999

                      Employees

                      635

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: